Nuo Therapeutics (AURX)
OTHER OTC:AURX
US Market
Holding AURX?
Track your performance easily

Nuo Therapeutics (AURX) Financial Statements

10 Followers

Nuo Therapeutics Financial Overview

Nuo Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.062; its P/E ratio is -8.84; Nuo Therapeutics is scheduled to report earnings on August 8, 2022, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 364.77K$ 197.01K$ 232.24K$ 118.17K$ 61.10K
Gross Profit$ 299.44K$ 407.83K$ 178.42K$ 97.68K$ 50.68K
EBIT$ -540.09K$ -653.15K$ -790.64K$ -871.89K$ -855.75K
EBITDA$ -520.19K$ -626.16K$ -764.25K$ -845.87K$ -829.91K
Net Income Common Stockholders$ -540.09K$ -653.15K$ -790.64K$ -871.89K$ -855.75K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 473.04K$ 928.68K$ 582.59K$ 399.37K$ 1.31M
Total Assets$ 1.42M$ 1.88M$ 1.60M$ 1.39M$ 2.22M
Total Debt$ 194.04K$ 255.59K$ 276.20K$ 296.31K$ 315.92K
Net Debt$ -279.00K$ -673.09K$ -306.39K$ -103.06K$ -989.34K
Total Liabilities$ 821.96K$ 838.73K$ 873.18K$ 914.44K$ 882.79K
Stockholders Equity$ 598.51K$ 1.04M$ 726.72K$ 470.83K$ 1.34M
Cash Flow-
Free Cash Flow$ -695.27K$ -671.41K$ -796.78K$ -905.89K$ 2.11M
Operating Cash Flow$ -691.17K$ -671.41K$ -794.88K$ -905.89K$ 2.11M
Investing Cash Flow$ -4.10K-$ -1.90K-$ -5.34K
Financing Cash Flow$ 802.08K$ 962.50K$ 1.03M--
Currency in USD

Nuo Therapeutics Earnings and Revenue History

Nuo Therapeutics Debt to Assets

Nuo Therapeutics Cash Flow

Nuo Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis